Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data

Sphingosine 1-phosphate (S1P) receptors are bioactive lipid metabolites that bind five different types of receptors expressed ubiquitously in human body and mediate a broad range of biological functions. Targeting S1P receptors is nowadays a well-established pharmacological strategy to treat multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggieri, Serena, Quartuccio, Maria Esmeralda, Prosperini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958267/
https://www.ncbi.nlm.nih.gov/pubmed/35356493
http://dx.doi.org/10.2147/DNND.S313825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958267/
https://www.ncbi.nlm.nih.gov/pubmed/35356493
http://dx.doi.org/10.2147/DNND.S313825

Ejemplares similares